Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1950)
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
87,508
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,900
Price
$63.69
Total Value
$121.00K
Shares Held After
87,908
% of Holdings
2.1%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
300
Price
$65.31
Total Value
$19.59K
Shares Held After
105,389
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
432,886
% of Holdings
0.1%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
20,735
Price
$62.61
Total Value
$1.30M
Shares Held After
89,808
% of Holdings
18.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
3,102
Price
$63.64
Total Value
$197.42K
Shares Held After
433,156
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
1,400
Price
$63.69
Total Value
$89.17K
Shares Held After
105,689
% of Holdings
1.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
28,796
Price
$62.66
Total Value
$1.80M
Shares Held After
436,258
% of Holdings
6.2%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
27,473
Price
$62.00
Total Value
$1.70M
Shares Held After
110,543
% of Holdings
19.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
13,874
Price
$62.63
Total Value
$868.96K
Shares Held After
107,089
% of Holdings
11.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
63,498
Price
$61.99
Total Value
$3.94M
Shares Held After
465,054
% of Holdings
12.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
21,926
Price
$62.03
Total Value
$1.36M
Shares Held After
120,963
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
98,197
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
3,000
Price
$63.65
Total Value
$190.95K
Shares Held After
98,467
% of Holdings
3.0%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
29,021
Price
$62.66
Total Value
$1.82M
Shares Held After
101,467
% of Holdings
22.2%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
63,907
Price
$61.99
Total Value
$3.96M
Shares Held After
130,488
% of Holdings
32.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,431
Price
$65.31
Total Value
$93.46K
Shares Held After
117,066
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,400
Price
$63.65
Total Value
$89.11K
Shares Held After
118,497
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
27,421
Price
$62.59
Total Value
$1.72M
Shares Held After
119,897
% of Holdings
18.6%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
71,938
Price
$62.05
Total Value
$4.46M
Shares Held After
147,318
% of Holdings
32.8%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
6,000
Price
$350.07
Total Value
$2.10M
Shares Held After
224,464
% of Holdings
2.6%
Ceribell, Inc. (CBLL)
Blumberg Scott — Chief Financial Officer
Shares
846
Price
$25.00
Total Value
$21.15K
Shares Held After
146,600
% of Holdings
0.6%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
20,846
Price
$25.03
Total Value
$521.78K
Shares Held After
746,345
% of Holdings
2.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
400
Price
$40.45
Total Value
$16.18K
Shares Held After
36,108
% of Holdings
1.1%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
600
Price
$40.38
Total Value
$24.23K
Shares Held After
9,900
% of Holdings
5.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
4,712
Price
$39.68
Total Value
$186.97K
Shares Held After
36,508
% of Holdings
11.4%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
4,338
Price
$39.65
Total Value
$172.00K
Shares Held After
10,500
% of Holdings
29.2%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
1,195
Price
$27.00
Total Value
$32.27K
Shares Held After
395,794
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne — Director
Shares
3,000
Price
$28.58
Total Value
$85.74K
Shares Held After
6,200
% of Holdings
32.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
6,657
Price
$17.03
Total Value
$113.40K
Shares Held After
213,476
% of Holdings
3.0%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
3,328
Price
$17.03
Total Value
$56.69K
Shares Held After
220,133
% of Holdings
1.5%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
3,329
Price
$17.03
Total Value
$56.71K
Shares Held After
223,461
% of Holdings
1.5%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
66
Price
$80.01
Total Value
$5.28K
Shares Held After
94,487
% of Holdings
0.1%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
759
Price
$79.00
Total Value
$59.96K
Shares Held After
94,553
% of Holdings
0.8%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
11,675
Price
$78.33
Total Value
$914.50K
Shares Held After
95,312
% of Holdings
10.9%
Hims&Hers Health, Inc. (HIMS)
Chi Michael — Chief Operating Officer
Shares
14,027
Price
$28.39
Total Value
$398.23K
Shares Held After
456,660
% of Holdings
3.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
100,000
Price
$13.67
Total Value
$1.37M
Shares Held After
467,969
% of Holdings
17.6%
Hims&Hers Health, Inc. (HIMS)
Elshenawy Mohamed — CTO
Shares
7,954
Price
$28.39
Total Value
$225.81K
Shares Held After
185,556
% of Holdings
4.1%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
15,971
Price
$620.84
Total Value
$9.92M
Shares Held After
523,923
% of Holdings
3.0%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
13,985
Price
$120.49
Total Value
$1.69M
Shares Held After
183,200
% of Holdings
7.1%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
9,233
Price
$120.50
Total Value
$1.11M
Shares Held After
197,185
% of Holdings
4.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$24.18
Total Value
$114.37K
Shares Held After
35,841
% of Holdings
11.7%
Nakamoto Inc. (NAKA)
Evans Tyler Matthew — Director
Shares
982
Price
$7.63
Total Value
$7.49K
Shares Held After
576,764
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
1,400
Price
$39.24
Total Value
$54.94K
Shares Held After
39,068
% of Holdings
3.5%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
45,000
Price
$38.14
Total Value
$1.72M
Shares Held After
40,468
% of Holdings
52.7%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
8,667
Price
$38.27
Total Value
$331.72K
Shares Held After
10,500
% of Holdings
45.2%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
600
Price
$145.29
Total Value
$87.17K
Shares Held After
116,684
% of Holdings
0.5%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
800
Price
$144.46
Total Value
$115.57K
Shares Held After
117,284
% of Holdings
0.7%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
1,600
Price
$143.69
Total Value
$229.91K
Shares Held After
118,084
% of Holdings
1.3%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP Chief Legal Compliance Off
Shares
1,700
Price
$84.04
Total Value
$142.87K
Shares Held After
99,885
% of Holdings
1.7%
Showing 151–200 of 1950 transactions (page 4 of 39)